The company made the disclosures as part of Agilent's fiscal second-quarter earnings report, which showed that total revenues grew 16 percent and that a net loss in the prior-year period swung to a profit in the current quarter.
The firms will combine their mass spec and NMR technologies for metabolomic applications.
The revenue from the stimulus orders surpasses a $50 million estimate provided by the firm just a few months ago.
Bruker said that it booked orders from global stimulus programs, and it expects further orders from these programs through the rest of this year and into 2010.
In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.
At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.
The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.
Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.